SlideShare uma empresa Scribd logo
1 de 21
Technology and Intellectual Property Conference University of Toronto John W. Boscariol  March 2, 2009 The WTO TRIPS Agreement and  Pharmaceuticals DOCS #310412
Overview ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Why is the World Trade Organization relevant?  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Why is the World Trade Organization relevant?  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Why is the World Trade Organization relevant?  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Why is the World Trade Organization relevant?  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Canada and the WTO ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Canada and the WTO  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
What are the basic elements of TRIPS?  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Substantive Patent Protection under TRIPS  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Substantive Patent Protection Under TRIPS  ,[object Object],[object Object],[object Object],[object Object],[object Object]
TRIPS Jurisprudence  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
TRIPS and Pharmaceuticals for Developing Countries ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
TRIPS and Pharmaceuticals for Developing Countries ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
TRIPS and Pharmaceuticals for Developing Countries ,[object Object],[object Object],[object Object],[object Object]
TRIPS and Pharmaceuticals for Developing Countries ,[object Object],[object Object],[object Object],[object Object]
Data Protection and Data Exclusivity ,[object Object],[object Object],[object Object]
Data Protection and Data Exclusivity ,[object Object],[object Object],[object Object]
TRIPS - Plus ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Enforcement and Remedies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Vancouver P.O. Box 10424, Pacific Centre Suite 1300  777 Dunsmuir Street  Vancouver BC  V7Y 1K2 Tel: 604-643-7100  Fax: 604-643-7900 Calgary Suite 3300  421 – 7th Avenue SW Calgary AB  T2P 4K9 Tel: 403-260-3500  Fax: 403-260-3501  Toronto Box 48, Suite 5300  Toronto Dominion Bank Tower Toronto ON  M5K 1E6 Tel: 416-362-1812  Fax: 416-868-0673 Ottawa The Chambers Suite 1400  40 Elgin Street Ottawa ON  K1P 5K6 Tel: 613-238-2000  Fax: 613-563-9386 Montréal Suite 2500 1000 De La Gauchetière Street West Montréal QC  H3B 0A2 Tel: 514-397-4100  Fax: 514-875-6246 Québec Le Complexe St-Amable 1150, rue de Claire-Fontaine,  7 e  étage Québec QC  G1R 5G4 Tel: 418-521-3000  Fax: 418-521-3099 United Kingdom & Europe 5 Old Bailey, 2nd Floor London, England  EC4M 7BA Tel: +44 (0)20 7489 5700  Fax: +44 (0)20 7489 5777

Mais conteúdo relacionado

Mais procurados

Marketing Authorization In The Eu
Marketing Authorization In The EuMarketing Authorization In The Eu
Marketing Authorization In The Euclarityeye
 
labelling of drugs and cosmetics in European Union
labelling of drugs and cosmetics in European Unionlabelling of drugs and cosmetics in European Union
labelling of drugs and cosmetics in European UnionBindu Kshtriya
 
Marketing authorization procedures in eu
Marketing authorization procedures in euMarketing authorization procedures in eu
Marketing authorization procedures in euRajaniKarpur
 
Intellectual Property Rights of Pharmaceuticals
Intellectual Property Rights of Pharmaceuticals Intellectual Property Rights of Pharmaceuticals
Intellectual Property Rights of Pharmaceuticals Hemanga Hazarika
 
Risk Based Classification of Medical Devices and grouping
Risk Based Classification of Medical Devices and groupingRisk Based Classification of Medical Devices and grouping
Risk Based Classification of Medical Devices and groupingPaulyne Wairimu
 
EU REGULATORY SUBMISSIONS
EU REGULATORY SUBMISSIONSEU REGULATORY SUBMISSIONS
EU REGULATORY SUBMISSIONSChandra Mohan
 
EUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYEUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYdatchayani
 
Doha declaration
Doha declarationDoha declaration
Doha declarationvishnugm
 
US and EU Submission – Comparative
US and EU Submission – ComparativeUS and EU Submission – Comparative
US and EU Submission – ComparativeGirish Swami
 
Pakistan Drug Pricing Policy
Pakistan Drug Pricing PolicyPakistan Drug Pricing Policy
Pakistan Drug Pricing PolicyCepal & Co.
 
Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Aakashdeep Raval
 
Key terms Patent Act Term #8: Bolar Exception
Key terms Patent Act  Term #8:  Bolar ExceptionKey terms Patent Act  Term #8:  Bolar Exception
Key terms Patent Act Term #8: Bolar ExceptionOrigiin IP Solutions LLP
 
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptxCLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptxFaizanShaikh204666
 
TRIPS Agreement (Part-1)
TRIPS Agreement (Part-1)TRIPS Agreement (Part-1)
TRIPS Agreement (Part-1)A K DAS's | Law
 
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTSPallavi Christeen
 

Mais procurados (20)

Marketing Authorization In The Eu
Marketing Authorization In The EuMarketing Authorization In The Eu
Marketing Authorization In The Eu
 
labelling of drugs and cosmetics in European Union
labelling of drugs and cosmetics in European Unionlabelling of drugs and cosmetics in European Union
labelling of drugs and cosmetics in European Union
 
Marketing authorization procedures in eu
Marketing authorization procedures in euMarketing authorization procedures in eu
Marketing authorization procedures in eu
 
Intellectual Property Rights of Pharmaceuticals
Intellectual Property Rights of Pharmaceuticals Intellectual Property Rights of Pharmaceuticals
Intellectual Property Rights of Pharmaceuticals
 
STED
STEDSTED
STED
 
Risk Based Classification of Medical Devices and grouping
Risk Based Classification of Medical Devices and groupingRisk Based Classification of Medical Devices and grouping
Risk Based Classification of Medical Devices and grouping
 
EU REGULATORY SUBMISSIONS
EU REGULATORY SUBMISSIONSEU REGULATORY SUBMISSIONS
EU REGULATORY SUBMISSIONS
 
EUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYEUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCY
 
Regulatory requirements for orphan drugs delivery
Regulatory requirements for orphan drugs deliveryRegulatory requirements for orphan drugs delivery
Regulatory requirements for orphan drugs delivery
 
Cfr 21 part 312
Cfr 21 part 312 Cfr 21 part 312
Cfr 21 part 312
 
Doha declaration
Doha declarationDoha declaration
Doha declaration
 
US and EU Submission – Comparative
US and EU Submission – ComparativeUS and EU Submission – Comparative
US and EU Submission – Comparative
 
Pakistan Drug Pricing Policy
Pakistan Drug Pricing PolicyPakistan Drug Pricing Policy
Pakistan Drug Pricing Policy
 
Pharmaceutical patent
Pharmaceutical patent Pharmaceutical patent
Pharmaceutical patent
 
Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.
 
Key terms Patent Act Term #8: Bolar Exception
Key terms Patent Act  Term #8:  Bolar ExceptionKey terms Patent Act  Term #8:  Bolar Exception
Key terms Patent Act Term #8: Bolar Exception
 
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptxCLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
 
TRIPS Agreement (Part-1)
TRIPS Agreement (Part-1)TRIPS Agreement (Part-1)
TRIPS Agreement (Part-1)
 
Compulsory license of Drugs
Compulsory   license   of DrugsCompulsory   license   of Drugs
Compulsory license of Drugs
 
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
 

Destaque

Compliance in cross border pharmaceutical trade
Compliance in cross border pharmaceutical tradeCompliance in cross border pharmaceutical trade
Compliance in cross border pharmaceutical tradeRemi ADESEUN
 
Crystina Riffel: Pharmaceutical Drug Policies
Crystina Riffel: Pharmaceutical Drug PoliciesCrystina Riffel: Pharmaceutical Drug Policies
Crystina Riffel: Pharmaceutical Drug Policiesmerlyna
 
Nciec trade remedies
Nciec trade remediesNciec trade remedies
Nciec trade remediestamlinh
 
Trade Regulations and Industrial Policies
Trade Regulations and Industrial PoliciesTrade Regulations and Industrial Policies
Trade Regulations and Industrial Policiesreoharsa
 
Various rounds of wto
Various rounds of wtoVarious rounds of wto
Various rounds of wtoDurga .A
 
STUDY OF THE NEPALESE PHARMACEUTICAL INDUSTRY
STUDY OF THE NEPALESE PHARMACEUTICAL INDUSTRYSTUDY OF THE NEPALESE PHARMACEUTICAL INDUSTRY
STUDY OF THE NEPALESE PHARMACEUTICAL INDUSTRYNiraj Bartaula
 
World trade organization
World trade organizationWorld trade organization
World trade organizationShimanto Deb
 
Regulatory Trends Of Pharmaceuticals I Bric Countries
Regulatory Trends Of Pharmaceuticals I Bric CountriesRegulatory Trends Of Pharmaceuticals I Bric Countries
Regulatory Trends Of Pharmaceuticals I Bric Countriesshivampharma88
 
WTO and its details by Arun Verma
WTO and its details by Arun VermaWTO and its details by Arun Verma
WTO and its details by Arun VermaArun Verma
 
Wto and implications for small and developing countries
Wto and implications for small and developing countriesWto and implications for small and developing countries
Wto and implications for small and developing countriesDavepres
 
Ch 38 gatt & wto
Ch 38 gatt & wtoCh 38 gatt & wto
Ch 38 gatt & wtoNikita
 

Destaque (20)

Trips plus edited
Trips plus editedTrips plus edited
Trips plus edited
 
Compliance in cross border pharmaceutical trade
Compliance in cross border pharmaceutical tradeCompliance in cross border pharmaceutical trade
Compliance in cross border pharmaceutical trade
 
Crystina Riffel: Pharmaceutical Drug Policies
Crystina Riffel: Pharmaceutical Drug PoliciesCrystina Riffel: Pharmaceutical Drug Policies
Crystina Riffel: Pharmaceutical Drug Policies
 
Trips and trims
Trips and trimsTrips and trims
Trips and trims
 
Nciec trade remedies
Nciec trade remediesNciec trade remedies
Nciec trade remedies
 
Trade Regulations and Industrial Policies
Trade Regulations and Industrial PoliciesTrade Regulations and Industrial Policies
Trade Regulations and Industrial Policies
 
Wto 1 Nitin
Wto 1 NitinWto 1 Nitin
Wto 1 Nitin
 
Various rounds of wto
Various rounds of wtoVarious rounds of wto
Various rounds of wto
 
ED - Seminar Work
ED - Seminar WorkED - Seminar Work
ED - Seminar Work
 
Het oog
Het oogHet oog
Het oog
 
STUDY OF THE NEPALESE PHARMACEUTICAL INDUSTRY
STUDY OF THE NEPALESE PHARMACEUTICAL INDUSTRYSTUDY OF THE NEPALESE PHARMACEUTICAL INDUSTRY
STUDY OF THE NEPALESE PHARMACEUTICAL INDUSTRY
 
World trade organization
World trade organizationWorld trade organization
World trade organization
 
Regulatory Trends Of Pharmaceuticals I Bric Countries
Regulatory Trends Of Pharmaceuticals I Bric CountriesRegulatory Trends Of Pharmaceuticals I Bric Countries
Regulatory Trends Of Pharmaceuticals I Bric Countries
 
WTO and its details by Arun Verma
WTO and its details by Arun VermaWTO and its details by Arun Verma
WTO and its details by Arun Verma
 
Wto Final
Wto FinalWto Final
Wto Final
 
Wto
WtoWto
Wto
 
WTO and Health
WTO and HealthWTO and Health
WTO and Health
 
Wto and implications for small and developing countries
Wto and implications for small and developing countriesWto and implications for small and developing countries
Wto and implications for small and developing countries
 
Ch 38 gatt & wto
Ch 38 gatt & wtoCh 38 gatt & wto
Ch 38 gatt & wto
 
Ipr trips&trims
Ipr trips&trimsIpr trips&trims
Ipr trips&trims
 

Semelhante a Pharmaceuticals and the WTO TRIPS Agreement

GSIPA2M, Plenary 3, Leaving TRIPS behind - Lorena di Giano
GSIPA2M, Plenary 3, Leaving TRIPS behind - Lorena di GianoGSIPA2M, Plenary 3, Leaving TRIPS behind - Lorena di Giano
GSIPA2M, Plenary 3, Leaving TRIPS behind - Lorena di GianoMakeMedicinesAffordable
 
Trips agreement / WHO / WTO agreements
Trips agreement / WHO / WTO agreementsTrips agreement / WHO / WTO agreements
Trips agreement / WHO / WTO agreementsNesnalNiraula
 
Opportunities for Reform: the EU FCFTA: what to look out for?
Opportunities for Reform: the EU FCFTA: what to look out for?Opportunities for Reform: the EU FCFTA: what to look out for?
Opportunities for Reform: the EU FCFTA: what to look out for?MakeMedicinesAffordable
 
Free Trade Zones: TRIPS Standards and Beyond
Free Trade Zones: TRIPS Standards and BeyondFree Trade Zones: TRIPS Standards and Beyond
Free Trade Zones: TRIPS Standards and BeyondOECD Governance
 
Access to Essential Medicines and Intellectual Property Aspects
Access to Essential Medicines and Intellectual Property AspectsAccess to Essential Medicines and Intellectual Property Aspects
Access to Essential Medicines and Intellectual Property AspectsMakeMedicinesAffordable
 
Intellectual Property Rights Seminar Report
Intellectual Property Rights Seminar ReportIntellectual Property Rights Seminar Report
Intellectual Property Rights Seminar ReportAjay Poshak
 
WTO Some Primary information and History
WTO Some Primary information and HistoryWTO Some Primary information and History
WTO Some Primary information and HistoryRam Deshpande
 
world trade organisation(WTO)
world trade organisation(WTO)world trade organisation(WTO)
world trade organisation(WTO)Kunal Poddar
 
UNAIDS - The Potential Impact of Free Trade Agreements on Public Health
UNAIDS  - The Potential Impact of Free Trade Agreements on Public HealthUNAIDS  - The Potential Impact of Free Trade Agreements on Public Health
UNAIDS - The Potential Impact of Free Trade Agreements on Public HealthESTHHUB
 

Semelhante a Pharmaceuticals and the WTO TRIPS Agreement (20)

GSIPA2M, Plenary 3, Leaving TRIPS behind - Lorena di Giano
GSIPA2M, Plenary 3, Leaving TRIPS behind - Lorena di GianoGSIPA2M, Plenary 3, Leaving TRIPS behind - Lorena di Giano
GSIPA2M, Plenary 3, Leaving TRIPS behind - Lorena di Giano
 
Lecture-4.pptx
Lecture-4.pptxLecture-4.pptx
Lecture-4.pptx
 
Trips agreement / WHO / WTO agreements
Trips agreement / WHO / WTO agreementsTrips agreement / WHO / WTO agreements
Trips agreement / WHO / WTO agreements
 
Opportunities for Reform: the EU FCFTA: what to look out for?
Opportunities for Reform: the EU FCFTA: what to look out for?Opportunities for Reform: the EU FCFTA: what to look out for?
Opportunities for Reform: the EU FCFTA: what to look out for?
 
Reforming EU export controls
Reforming EU export controlsReforming EU export controls
Reforming EU export controls
 
Free Trade Zones: TRIPS Standards and Beyond
Free Trade Zones: TRIPS Standards and BeyondFree Trade Zones: TRIPS Standards and Beyond
Free Trade Zones: TRIPS Standards and Beyond
 
Access to Essential Medicines and Intellectual Property Aspects
Access to Essential Medicines and Intellectual Property AspectsAccess to Essential Medicines and Intellectual Property Aspects
Access to Essential Medicines and Intellectual Property Aspects
 
Ceramics (1)
Ceramics (1)Ceramics (1)
Ceramics (1)
 
Uruguay ao a ppt
Uruguay ao a pptUruguay ao a ppt
Uruguay ao a ppt
 
Intellectual Property Rights Seminar Report
Intellectual Property Rights Seminar ReportIntellectual Property Rights Seminar Report
Intellectual Property Rights Seminar Report
 
Glossary en
Glossary enGlossary en
Glossary en
 
Relevance Of WTO
Relevance Of WTORelevance Of WTO
Relevance Of WTO
 
WTO Some Primary information and History
WTO Some Primary information and HistoryWTO Some Primary information and History
WTO Some Primary information and History
 
TRIMS.pptx
TRIMS.pptxTRIMS.pptx
TRIMS.pptx
 
world trade organisation(WTO)
world trade organisation(WTO)world trade organisation(WTO)
world trade organisation(WTO)
 
Restraints of Trade and Dominance in Cyprus
Restraints of Trade and Dominance in CyprusRestraints of Trade and Dominance in Cyprus
Restraints of Trade and Dominance in Cyprus
 
TRIPS.pptx
TRIPS.pptxTRIPS.pptx
TRIPS.pptx
 
Wto (1)
Wto (1)Wto (1)
Wto (1)
 
Trips; itl
Trips; itlTrips; itl
Trips; itl
 
UNAIDS - The Potential Impact of Free Trade Agreements on Public Health
UNAIDS  - The Potential Impact of Free Trade Agreements on Public HealthUNAIDS  - The Potential Impact of Free Trade Agreements on Public Health
UNAIDS - The Potential Impact of Free Trade Agreements on Public Health
 

Pharmaceuticals and the WTO TRIPS Agreement

  • 1. Technology and Intellectual Property Conference University of Toronto John W. Boscariol March 2, 2009 The WTO TRIPS Agreement and Pharmaceuticals DOCS #310412
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21. Vancouver P.O. Box 10424, Pacific Centre Suite 1300 777 Dunsmuir Street Vancouver BC V7Y 1K2 Tel: 604-643-7100 Fax: 604-643-7900 Calgary Suite 3300 421 – 7th Avenue SW Calgary AB T2P 4K9 Tel: 403-260-3500 Fax: 403-260-3501 Toronto Box 48, Suite 5300 Toronto Dominion Bank Tower Toronto ON M5K 1E6 Tel: 416-362-1812 Fax: 416-868-0673 Ottawa The Chambers Suite 1400 40 Elgin Street Ottawa ON K1P 5K6 Tel: 613-238-2000 Fax: 613-563-9386 Montréal Suite 2500 1000 De La Gauchetière Street West Montréal QC H3B 0A2 Tel: 514-397-4100 Fax: 514-875-6246 Québec Le Complexe St-Amable 1150, rue de Claire-Fontaine, 7 e étage Québec QC G1R 5G4 Tel: 418-521-3000 Fax: 418-521-3099 United Kingdom & Europe 5 Old Bailey, 2nd Floor London, England EC4M 7BA Tel: +44 (0)20 7489 5700 Fax: +44 (0)20 7489 5777